Company: CDLX
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001666071-25-000046
Chunk: 95

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 95
---
1,269 |     |   |   -3,304 |     |   |    6,376 |     |   |    1,267 |     |   |  -1,549 |
| Impairment of goodwill and intangible assets              |     |                         |  131,595 |     |   |   70,518 |     |   |  453,288 |     |   |        — |     |   |       — |
| Gain on debt extinguishment                               |     |                         |  -13,017 |     |   |        — |     |   |        — |     |   |        — |     |   |       — |
| Loss on divestiture                                       |     |                         |        — |     |   |    6,550 |     |   |        — |     |   |        — |     |   |       — |
| Restructuring and reduction of force                      |     |                         |        — |     |   |        — |     |   |    8,139 |     |   |      713 |     |   |   1,323 |
| Income tax benefit                                        |     |                         |        — |     |   |        — |     |   |   -1,446 |     |   |   -7,864 |     |   |       — |
| Deferred implementation costs                             |     |                         |        — |     |   |        — |     |   |        — |     |   |    3,785 |     |   |   4,598 |
| Adjusted EBITDA                                           |     | $                       |    2,523 |     | $ |    3,771 |     | $ |  -45,169 |     | $ |  -12,220 |     | $ |  -7,780 |

<div align='center'>67</div>

### APPENDIX B

#### Cardlytics, Inc.

#### 2025 Equity Incentive Plan
<div align='center'>Adopted by the Board of Directors: February 12, 2025</div>

#### Approved by the Stockholders: ________, 2025

#### 1.

#### General.
(a) Successor to and Continuation of Prior Plan. The Plan is intended as the successor to and continuation of the Company’s 2018 Equity Incentive Plan (the “ Prior Plan